NOVOCIB produces active nucleoside kinases and other nucleotide metabolism enzymes. This portfolio of enzymes represents a unique range of powerful tools for Drug Discovery and research in the field of nucleoside and nucleotide metabolism.
IMPDH |
Inosine Monophosphate Dehydrogenase (EC 1.1.1.205) | Human Type II, recombinant, expressed in E.coli Bacterial (Staphylococcus aureus) recombinant, expressed in E.coli |
PNP |
Purine Nucleoside Phosphorylase (EC 2.4.2.1) | Human recombinant, expressed in E.coli |
HGPRT |
Hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8) | Human recombinant, expressed in E.coli |
Know more about NOVOCIB'S Purine Metabolism Enzymes
ADK |
Adenosine Kinase (EC 2.7.1.20) | Human, recombinant, expressed in E.coli |
dCK |
Deoxycytidine Kinase (EC 2.7.1.74) | Human recombinant, expressed in E.coli |
CMK |
UMP-CMP Kinase (EC 2.7.4.14) | Human recombinant, expressed in E.coli |
cN-II |
Cytosolic 5'-nucleotidase II (EC 3.1.3.5) | Human recombinant, expressed in E.coli |
Know more about NOVOCIB'S Nucleoside Kinases
Bacterial Luciferase |
(EC 1.14.14.3) | Bacterial, produced from a selected strain of Photobacterium phosphoreum |
FMN Reductase |
(EC 1.5.1.29) | Bacterial recombinant, E.coli |
Bacterial bioluminescence consists in a ligh-emitting reaction where a long-chain aliphatic aldehyde is oxidized in the presence of molecular oxygen and reduced flavin mononucleotide (FMNH2). This reaction is catalyzed by bacterial luciferase.
NOVOCIB offers a highly pure bacterial luciferase from Photobacterium phosphoreum and a recombinant FMN-Reductase which, when coupled to bacterial luciferase in vitro, is able to significantly increase the sensitivity and allow a better control of signal intensity and duration.
Know more about NOVOCIB'S Bacterial Bioluminescence Enzymes